Unknown

Dataset Information

0

The Bacterial Microbiota of Gastrointestinal Cancers: Role in Cancer Pathogenesis and Therapeutic Perspectives.


ABSTRACT: The microbiota has an essential role in the pathogenesis of many gastrointestinal diseases including cancer. This effect is mediated through different mechanisms such as damaging DNA, activation of oncogenic pathways, production of carcinogenic metabolites, stimulation of chronic inflammation, and inhibition of antitumor immunity. Recently, the concept of "pharmacomicrobiomics" has emerged as a new field concerned with exploring the interplay between drugs and microbes. Mounting evidence indicates that the microbiota and their metabolites have a major impact on the pharmacodynamics and therapeutic responses toward anticancer drugs including conventional chemotherapy and molecular?-targeted therapeutics. In addition, microbiota appears as an attractive target for cancer prevention and treatment. In this review, we discuss the role of bacterial microbiota in the pathogenesis of different cancer types affecting the gastrointestinal tract system. We also scrutinize the evidence regarding the role of microbiota in anticancer drug responses. Further, we discuss the use of probiotics, fecal microbiota transplantation, and antibiotics, either alone or in combination with anticancer drugs for prevention and treatment of gastrointestinal tract cancers.

SUBMITTER: Elsalem L 

PROVIDER: S-EPMC7211962 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

The Bacterial Microbiota of Gastrointestinal Cancers: Role in Cancer Pathogenesis and Therapeutic Perspectives.

Elsalem Lina L   Jum'ah Ahmad A AA   Alfaqih Mahmoud A MA   Aloudat Osama O  

Clinical and experimental gastroenterology 20200506


The microbiota has an essential role in the pathogenesis of many gastrointestinal diseases including cancer. This effect is mediated through different mechanisms such as damaging DNA, activation of oncogenic pathways, production of carcinogenic metabolites, stimulation of chronic inflammation, and inhibition of antitumor immunity. Recently, the concept of "pharmacomicrobiomics" has emerged as a new field concerned with exploring the interplay between drugs and microbes. Mounting evidence indicat  ...[more]

Similar Datasets

| S-EPMC8507552 | biostudies-literature
| S-EPMC3264936 | biostudies-other
| S-EPMC8196771 | biostudies-literature
| S-EPMC7697442 | biostudies-literature
| S-EPMC8156220 | biostudies-literature
| S-EPMC7916411 | biostudies-literature
| S-EPMC3826836 | biostudies-literature
| S-EPMC4108072 | biostudies-literature
| S-EPMC5864716 | biostudies-other
| S-EPMC7753360 | biostudies-literature